TP53 and neoplasm: Tang et al. [168] engineered luteinizing hormone-releasing hormone (LHRH) peptide-conjugated nanocapsules that effectively facilitated the targeted delivery of recombinant human p53 proteins to LHRH receptor-expressing tumor cells, resulting in the reactivation of apoptosis in these cells.